TIGIT and glioblastoma: In patients with GBM, high expression of CD47, TIGIT, and both CD47/TIGIT significantly decreased OS (P < 0.005, Figures 5G–I), indicating high expression levels of CD47 and TIGIT may be valuable indicators of a poor prognosis in patients with ADG.